{"id":5723,"date":"2024-05-07T11:16:00","date_gmt":"2024-05-07T16:16:00","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5723"},"modified":"2025-06-27T11:43:50","modified_gmt":"2025-06-27T16:43:50","slug":"nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001ASGCT\u5e74\u6b21\u7dcf\u4f1a\u304a\u3088\u3073\u4e16\u754c\u7db2\u819c\u4f1a\u8b70\u3067\u306e\u767a\u8868\u3092\u767a\u8868"},"content":{"rendered":"
\n
\n
\n

<\/h2>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02024\u5e745\u67087\u65e5<\/span><\/span>\u00a0\/PRNewswire\/ \u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u5f8c\u671f\u81e8\u5e8a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u30a6\u30a4\u30eb\u30b9\u304a\u3088\u3073\u30ec\u30fc\u30b6\u30fc\u9001\u9054\u578b\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u3001\u00a02024 ASGCT\u5e74\u6b21\u7dcf\u4f1a<\/a>\u00a0\u305d\u3057\u3066\u305d\u306e\u00a0\u7db2\u819c\u4e16\u754c\u4f1a\u8b70<\/a>\u3001\u958b\u50ac\u4e2d\u00a0\u30e1\u30ea\u30fc\u30e9\u30f3\u30c9\u5dde\u30dc\u30eb\u30c1\u30e2\u30a2<\/span>\u00a0\u305d\u3057\u3066\u00a0\u30d5\u30ed\u30ea\u30c0\u5dde\u30d5\u30a9\u30fc\u30c8\u30ed\u30fc\u30c0\u30fc\u30c7\u30fc\u30eb<\/span>\u3001\u305d\u308c\u305e\u308c5\u6708\u306b\u3002<\/p>\n

\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n

2024\u5e74\u30a2\u30e1\u30ea\u30ab\u907a\u4f1d\u5b50\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\uff08ASGCT\uff09\u5e74\u6b21\u7dcf\u4f1a<\/a><\/b><\/p>\n

\u8981\u7d04\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u4f4e\u7528\u91cf\u307e\u305f\u306f\u9ad8\u7528\u91cfMCO-010\u5909\u7570\u975e\u4f9d\u5b58\u578b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u306b\u304a\u3051\u308bBCVA\u3068\u8fd1\u63a5\u5834\u7269\u4f53\u8a8d\u8b58\u306e\u7e26\u65ad\u7684\u5206\u6790\uff1a\u30d5\u30a7\u30fc\u30ba1\u8a66\u9a13\u306e12\u304b\u6708\u306e\u7d50\u679c\u00a02b<\/span>\/3 \u30e9\u30f3\u30c0\u30e0\u5316\u3001\u507d\u5bfe\u7167\u3001\u60a3\u8005\u304a\u3088\u3073\u8a55\u4fa1\u8005\u76f2\u691c\u81e8\u5e8a\u8a66\u9a13 (RESTORE)<\/a>
\n\u8981\u65e8\/\u30dd\u30b9\u30bf\u30fc\u756a\u53f7:<\/b>\u00a0917
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30d7:\u00a0<\/b>\u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f3
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u6c34\u66dc\u65e5\u306e\u30dd\u30b9\u30bf\u30fc\u767a\u8868\uff1a\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u81e8\u5e8a\u8a66\u9a13 \u2013 \u751f\u4f53\u5185\u6539\u5909
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u67088\u65e5
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>12:00\uff5e\u00a0\u5348\u5f8c7\u6642\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/span>
\n\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30fc\u30cd\u533b\u5b66\u535a\u58eb\u3001\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005<\/p>\n

\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u907a\u4f1d\u5b50\u306e\u975e\u30a6\u30a4\u30eb\u30b9\u6a19\u7684\u30ec\u30fc\u30b6\u30fc\u9001\u9054<\/a>
\n\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u756a\u53f7:<\/b>\u00a0426
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30d7:\u00a0<\/b>\u53e3\u982d\u767a\u8868\u30bb\u30c3\u30b7\u30e7\u30f3
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u306b\u5411\u3051\u305f\u975e\u30a6\u30a4\u30eb\u30b9\u30a2\u30d7\u30ed\u30fc\u30c1
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u670811\u65e5
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>11:15 \u2013\u00a0\u5348\u524d11\u664230\u5206\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/span>
\n\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p>\n

\u3053\u306e\u8b1b\u6f14\u3067\u306f\u3001\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u304c\u3001\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306b\u4f34\u3046\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u8fd1\u8d64\u5916\u7dda\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u9032\u6b69\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002<\/p>\n

\u7db2\u819c\u4e16\u754c\u4f1a\u8b70 2024<\/a><\/b><\/p>\n

\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0IRD \u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u3001\u85ac\u7269\u7642\u6cd5\u3001\u5149\u907a\u4f1d\u5b66
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u67089\u65e5
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a09:05 \u2013\u00a0\u5348\u524d9\u664235\u5206\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/span>
\n\u4f4d\u7f6e\uff1a<\/b>\u00a0\u30d5\u30a9\u30fc\u30c8\u30ed\u30fc\u30c0\u30fc\u30c7\u30fc\u30eb \u30de\u30ea\u30aa\u30c3\u30c8 \u30cf\u30fc\u30d0\u30fc \u30d3\u30fc\u30c1 \u30db\u30c6\u30eb
\n\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc<\/b>: \u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u5909\u6027\u75c7\uff08IRD\uff09\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u5909\u7570\u306e\u7a2e\u985e\u3092\u554f\u308f\u306a\u3044\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u85acMCO-010\u306b\u95a2\u3059\u308b\u6700\u65b0\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u305d\u306e\u5f8c\u3001\u30af\u30ea\u30fc\u30d6\u30e9\u30f3\u30c9\u30fb\u30af\u30ea\u30cb\u30c3\u30af\u30fb\u30e9\u30fc\u30ca\u30fc\u533b\u79d1\u5927\u5b66\u30b3\u30fc\u30eb\u773c\u79d1\u7814\u7a76\u6240\u306e\u773c\u79d1\u5b66\u6559\u6388\u3067\u3042\u308b\u30d4\u30fc\u30bf\u30fc\u30fb\u30ab\u30a4\u30b6\u30fc\u533b\u5e2b\u304c\u53f8\u4f1a\u3092\u52d9\u3081\u308b\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304c\u884c\u308f\u308c\u307e\u3059\u3002.<\/p>\n

\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u5909\u7570\u975e\u4f9d\u5b58\u578bMCO-010\u5149\u907a\u4f1d\u5b66\u7684\u7642\u6cd5\u306e\u9577\u671f\u7684BCVA\u3068\u5b89\u5168\u6027\u5206\u6790\uff1a\u30d5\u30a7\u30fc\u30ba1\u306e\u60a3\u8005\u4e8b\u4f8b\u00a02b<\/span>\u00a0\u30e9\u30f3\u30c0\u30e0\u5316\u3001\u6a21\u64ec\u5bfe\u7167\u3001\u60a3\u8005\u304a\u3088\u3073\u8a55\u4fa1\u8005\u76f2\u691c\u81e8\u5e8a\u8a66\u9a13 (RESTORE)
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u907a\u4f1d\u5b50\u304a\u3088\u3073\u7d30\u80de\u6cbb\u7642
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e745\u670810\u65e5
\n\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a02:21 \u2013\u00a0\u5348\u5f8c2\u664226\u5206<\/span>
\n\u4f4d\u7f6e\uff1a<\/b>\u00a0\u30d5\u30a9\u30fc\u30c8\u30ed\u30fc\u30c0\u30fc\u30c7\u30fc\u30eb \u30de\u30ea\u30aa\u30c3\u30c8 \u30cf\u30fc\u30d0\u30fc \u30d3\u30fc\u30c1 \u30db\u30c6\u30eb
\n\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc<\/b>: \u30af\u30ea\u30b9\u30c6\u30a3\u30f3\u30fb\u30b1\u30a4\u533b\u5b66\u535a\u58eb\u3001\u30b2\u30a4\u30f3\u30ba\u30d3\u30eb\u306eVitreoretinal Associates\u306e\u96fb\u6c17\u751f\u7406\u5b66\u3001\u7db2\u819c\u907a\u4f1d\u5b66\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u00a0\u30d5\u30ed\u30ea\u30c0<\/span>\u3001\u304a\u3088\u3073\u5927\u5b66\u51c6\u6559\u6388\u00a0\u5357\u30d5\u30ed\u30ea\u30c0<\/span>.<\/p>\n

\u30b1\u30a4\u535a\u58eb\u306f\u3001RESTORE \u8a66\u9a13\u3067 MCO-010 \u306b\u3088\u308b\u6cbb\u7642\u3092\u53d7\u3051\u305f\u9032\u884c\u6027\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7 (RP) \u60a3\u8005\u306b\u304a\u3044\u3066\u9577\u671f\u7684\u306b\u89b3\u5bdf\u3055\u308c\u305f\u3001\u7d71\u8a08\u7684\u306b\u6709\u610f\u304b\u3064\u81e8\u5e8a\u7684\u306b\u610f\u5473\u306e\u3042\u308b\u8996\u529b\u6539\u5584\u306b\u3064\u3044\u3066\u8a73\u3057\u304f\u8aac\u660e\u3057\u307e\u3059\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
\n<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u3002\u540c\u793e\u306e\u4e3b\u529b\u88fd\u54c1\u3067\u3042\u308bMCO-010\u306f\u3001\u00a0\u6700\u8fd1\u767a\u8868\u3055\u308c\u305f100\u9031\u9593\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u3001<\/a>\u00a0\u5fa9\u5143\u30d5\u30a7\u30fc\u30ba\u00a02b<\/span>\u00a0\u7c73\u56fd\u306b\u304a\u3051\u308bRP\u306b\u5bfe\u3059\u308b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (NCT05417126<\/a>\uff09\u3002MCO-010 \u306f\u3001RP \u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066 FDA \u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068 FDA \u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001AMD \u306b\u3088\u308b GA \u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054 MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
\n212-600-1902
\nPR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0May 7, 2024\u00a0\/PRNewswire\/ \u2014\u00a0Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that its viral and laser-delivered Multi-Characteristic Opsin (MCO) gene therapy platforms will be featured in multiple presentations at the\u00a02024 ASGCT Annual Meeting\u00a0and the\u00a0Retina World Congress, being held in\u00a0Baltimore, Maryland\u00a0and\u00a0Fort Lauderdale, Florida, respectively, in May. Details are as follows: 2024 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting Abstract Title:\u00a0Longitudinal Analysis of BCVA and Near-Field Object Recognition in Low- or High-Dose MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase\u00a02b\/3 Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE) Abstract\/Poster Number:\u00a0917 Session Type:\u00a0Poster Session Session Title:\u00a0Wednesday […]<\/p>\n","protected":false},"author":6,"featured_media":5711,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T16:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:43:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ARVO_LI_2024._V2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ARVO_LI_2024._V2.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress\",\"datePublished\":\"2024-05-07T16:16:00+00:00\",\"dateModified\":\"2025-06-27T16:43:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/\"},\"wordCount\":539,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/\",\"name\":\"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg\",\"datePublished\":\"2024-05-07T16:16:00+00:00\",\"dateModified\":\"2025-06-27T16:43:50+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg\",\"width\":2000,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/07\\\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001ASGCT\u5e74\u6b21\u7dcf\u4f1a\u304a\u3088\u3073\u7db2\u819c\u4e16\u754c\u4f1a\u8b70\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-05-07T16:16:00+00:00","article_modified_time":"2025-06-27T16:43:50+00:00","og_image":[{"width":2000,"height":2000,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ARVO_LI_2024._V2.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ARVO_LI_2024._V2.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress","datePublished":"2024-05-07T16:16:00+00:00","dateModified":"2025-06-27T16:43:50+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/"},"wordCount":539,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/","url":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001ASGCT\u5e74\u6b21\u7dcf\u4f1a\u304a\u3088\u3073\u7db2\u819c\u4e16\u754c\u4f1a\u8b70\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg","datePublished":"2024-05-07T16:16:00+00:00","dateModified":"2025-06-27T16:43:50+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_ASGCT_RetinaWorld_LI_2024._V2.jpg","width":2000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/07\/nanoscope-therapeutics-announces-presentations-in-upcoming-asgct-annual-meeting-and-retina-world-congress-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5723"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5723\/revisions"}],"predecessor-version":[{"id":9042,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5723\/revisions\/9042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5711"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}